The path to wiping out cervical cancer looks increasingly clear – at least for high-income countries with strong uptake of the human papillomavirus (HPV) vaccine and cervical screening…. read more.
The European Medicines Agency (EMA) has been nominated for the European Ombudsman Award for Good Administration. The Agency’s One Health Instagram account is shortlisted in the ‘Excellence in… read more.
People born with heart defects experience their first acute heart attack at a significantly earlier age than others, according to a new national study from Lund University in… read more.
The European Medicines Agency (EMA) has unveiled a new communications effort designed to inform evidence-based decision-making. Vaccine Essentials offers healthcare professionals accessible summaries of how the quality, safety… read more.
Nurse-led, community-based ultrasound screening for hip dysplasia achieved almost universal reach and identified children earlier than current practices. A University of Tokyo study found that 8.7% of infants… read more.
A new study suggests that probiotics supplementation during early pregnancy may help reduce the risk of recurrent spontaneous preterm delivery (sPTD). In a multicentre clinical trial, pregnant women… read more.
Flu vaccination could significantly reduce the risk of influenza-associated heart attack and stroke even among people who get infected after getting the vaccine, according to research published in… read more.
A new blood test, using a marker for late-stage Alzheimer’s disease, could offer a clinically relevant dementia diagnosis with fewer false positives, according to researchers at Lund University… read more.
GLP-1 medications are associated with a reduced need for psychiatric hospital care and fewer employee sick days. They also appear to lower the risk of substance use disorders…. read more.
The European Medicines Agency (EMA) has launched three major new features of PRIME, the Agency’s scheme to enhance support for the development of medicines targeting an unmet medical… read more.
The EU’s drug regulator, the European Medicines Agency (EMA), has issued recommendations for the influenza virus strains that vaccine manufacturers should include from autumn 2026. Every year, EMA… read more.
The European Medicines Agency’s key human medicines committee (CHMP) has recommended five medicines for approval at its March 2026 meeting. This brings to 23 the total number of… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
